drugset / Trial / NCT07617688
Evaluation of the Pharmacokinetics, Biodistribution and Radiation Dosimetry of [18F]MODAG-009 Positron Emission Tomography (PET) Radiotracers in Adult Healthy Volunteers
Phase 0
Recruiting
6 enrolled
MODAG GmbH
Institute for Neurodegenerative Disorders · collabXingImaging, LLC · collab
NaSingle-groupOpen-labelDiagnostic
Summary
This is an open-label, single-center, phase 1 study to further characterize \[18F\]MODAG-009 in Healthy Volunteers (HV). Approximately 6 participants will be enrolled in this study. Each participant will receive a single dose of \[18F\]MODAG-009 radiotracer and undergo whole body PET imaging covering up to 10 bed positions to capture the whole body from skull vertex to mid-thigh.
Timeline
- Start
- 2026-05-27
- Primary completion
- 2027-05
- Completion
- 2027-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [¹⁸F]MODAG-009 | Diagnostic / imaging agent | — | Intravenous |
Indications
No indication recorded.